GlassScriptPhysician profile
Jennifer Stark
NPI 1063763548
$5,133.14
in general payments reported to CMS, 2019-2025
11 companies · $3,193 in 2025
The $3,193 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $148 · 2021: $1,019 · 2022: $533 · 2023: $58.11 · 2024: $182 · 2025: $3,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $932.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $2,964.53 | 2024-2025 | |
| Sientra, INC. | $956.65 | 2021-2022 | |
| Mentor Worldwide LLC | $362.30 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $313.27 | 2024-2025 | |
| Galderma Laboratories, L.P. | $301.59 | 2021-2023 | |
| Allergan, INC. | $64.07 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $63.31 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $36.88 | 2020-2021 | |
| Integra Lifesciences Corporation | $33.34 | 2025 | Integra, Surgimend, Omnigraft |
| Genzyme Corporation | $18.83 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $18.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.